WANT TO BE A SUCCESSFUL TRADER or INVESTOR? LEARN FROM EXPERTS | CALL: +919108911590 | Info@tradingcoach.co.in

Tag Archives: Price Action

Consolidation after an Upswing, Traders should focus on the Price Action

ICICI Bank Price action – Focus on the Minor Consolidation

By Trading Predator May 8th, 2018 No Comments

ICICI Bank Share prices are undergoing major structural changes. From Feb to April, Market was in downtrend. In Mid-April, prices broke the key support zone at 275, but later bounced back with strong momentum. This movement acted as a precursor of changing market sentiment. I have already pointed out these developments in earlier article. Here’s

SBI Price action and Momentum is divergining

State Bank Price Action – A Shift in Market Momentum

By Trading Predator March 23rd, 2018 No Comments

From last couple of Weeks, Most of the stocks are exhibiting a tendency for either trend continuation or Trend reversal. My previous two articles were also based on Trend analysis. This time it’s about the downtrend in 4h chart of India’s largest public sector lender – SBI or State Bank of India. SBI Price Action

Nifty Price action is trading at all time highs, as we move towards the 2018 Govt Budget

2018 budget and its impact on stock market Price action

By Trading Predator January 24th, 2018 No Comments

This is the time where Traders in Dalal Street wait eagerly for the Union budget to witness its impact of Stock market Price action. The Government Union budget is one of the most influencing macro events on the stock markets and overall economy of the country.Every major stock has a tendency to show volatility before

Lupin Share prices - Price action indicates a change in market structure.

Lupin – Price action structure changes, Downtrend termination ?

By Trading Predator November 2nd, 2017 No Comments

Just like other Pharma sector companies, Overall structure is a downtrend or what we can refer from Price action perspective as classical Mark down phase. (Lupin Share prices tumbled from 1500 to 918.) The second largest drug making company in India reported net profit of 662.9 crores in recent Q2 report – recorded strongest growth